Abstract
Precision medicine in type 2 diabetes mellitus: Unraveling the role of TCF7L2, CTRB1/2, and GLP-1R genetic variants in response to treatment with glucagon-like peptide-1 receptor agonists
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have